{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:50:50Z","timestamp":1793235050122,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-025-05446-y","type":"journal-article","created":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T19:47:56Z","timestamp":1750016876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of chloroquine with primaquine for uncomplicated Plasmodium vivax malaria without G6PD testing in Northwest Ethiopia: a one-arm in vivo prospective therapeutic efficacy study"],"prefix":"10.1186","volume":"24","author":[{"given":"Eyob","family":"Getu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdissa","family":"Biruksew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teferi","family":"Eshetu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhakim","family":"Abamecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit Getachew","family":"Assefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas","family":"Wuletaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geremew","family":"Tasew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew","family":"Tollera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesay","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moges","family":"Kassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashenafi","family":"Assefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bokretsion G.","family":"Brhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,15]]},"reference":[{"key":"5446_CR1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511581304","volume-title":"District laboratory practice in tropical countries (part 1)","author":"M Chesbrough","year":"2005","unstructured":"Chesbrough M. District laboratory practice in tropical countries (part 1). Cambridge University Press; 2005."},{"key":"5446_CR2","doi-asserted-by":"publisher","first-page":"4670","DOI":"10.1111\/j.1742-4658.2007.05997.x","volume":"274","author":"R Tuteja","year":"2007","unstructured":"Tuteja R. Malaria\u2014an overview. FEBS J. 2007;274:4670\u20139.","journal-title":"FEBS J"},{"key":"5446_CR3","volume-title":"Guidelines for malaria vector control","author":"L Choi","year":"2019","unstructured":"Choi L, Pryce J, Richardson M, Lutje V, Walshe D, Garner P. Guidelines for malaria vector control. Geneva: World Health Organization; 2019."},{"key":"5446_CR4","unstructured":"WHO. Guidelines for malaria, 2023. Geneva, World Health Organization; 2023. https:\/\/www.mmv.org\/sites\/default\/files\/content\/document\/WHO-UCN-GMP-2023.01-eng.pdf."},{"key":"5446_CR5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","volume":"167","author":"AF Cowman","year":"2016","unstructured":"Cowman AF, Healer J, Marapana D, Marsh K. Malaria: biology and disease. Cell. 2016;167:610\u201324.","journal-title":"Cell"},{"key":"5446_CR6","volume-title":"World malaria report 2024","author":"WHO","year":"2024","unstructured":"WHO. World malaria report 2024. Geneva: World Health Organization; 2024."},{"key":"5446_CR7","unstructured":"WHO. World malaria report 2023. Geneva: World Health Organization; 2023. https:\/\/cdn.who.int\/media\/docs\/default-source\/malaria\/world-malaria-reports\/world-malaria-report-2023-spreadview.pdf."},{"key":"5446_CR8","volume-title":"Malaria eradication: benefits, future scenarios and feasibility. A report of the strategic advisory group on malaria eradication","author":"WHO","year":"2020","unstructured":"WHO. Malaria eradication: benefits, future scenarios and feasibility. A report of the strategic advisory group on malaria eradication. Geneva: World Health Organization; 2020."},{"key":"5446_CR9","unstructured":"WHO. Global technical strategy for malaria 2016\u20132030. Geneva: World Health Organization; 2015. https:\/\/www.who.int\/docs\/default-source\/documents\/global-technical-strategy-for-malaria-2016-2030.pdf."},{"key":"5446_CR10","unstructured":"Federal Ministry of Health Ethiopia. Malaria elimination strategic plan: 2021\u20132025. Ethiopia, Addis Ababa; 2020. http:\/\/dataverse.nipn.ephi.gov.et\/bitstream\/handle\/123456789\/1526\/Ethiopia-Malaria-Elimination-Strategic-Plan-2021-2025-Agust-31.pdf?sequence=1."},{"key":"5446_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1051\/parasite\/2014059","volume":"21","author":"S Sinha","year":"2014","unstructured":"Sinha S, Medhi B, Sehgal R. Challenges of drug-resistant malaria. Parasite. 2014;21:61.","journal-title":"Parasite"},{"key":"5446_CR12","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(89)91792-3","volume":"334","author":"K Rieckmann","year":"1989","unstructured":"Rieckmann K, Davis D, Hutton D. Plasmodium vivax resistance to chloroquine? Lancet. 1989;334:1183\u20134.","journal-title":"Lancet"},{"key":"5446_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0035-9203(96)90322-3","volume":"90","author":"AN Tulu","year":"1996","unstructured":"Tulu AN, Webber RH, Schellenberg JA, Bradley DJ. Failure of chloroquine treatment for malaria in the highlands of Ethiopia. Trans R Soc Trop Med Hyg. 1996;90:556\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"5446_CR14","unstructured":"WHO. Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019). Geneva: World Health Organization; 2020. https:\/\/iris.who.int\/bitstream\/handle\/10665\/336692\/9789240012813-eng.pdf?sequence=1."},{"key":"5446_CR15","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1128\/AAC.48.11.4075-4083.2004","volume":"48","author":"JK Baird","year":"2004","unstructured":"Baird JK. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother. 2004;48:4075\u201383.","journal-title":"Antimicrob Agents Chemother"},{"key":"5446_CR16","unstructured":"Federal Democratic Republic of Ethiopia Ministry of Health: National malaria guideline, 4th Edn, Ethiopia, Addis Ababa; 2017. https:\/\/reliefweb.int\/report\/ethiopia\/ethiopia-national-malaria-guidelines-fourth-edition-november-2017."},{"key":"5446_CR17","unstructured":"WHO. Methods for surveillance of antimalarial drug efficacy. Geneva: World Health Organization; 2009. https:\/\/www.who.int\/publications\/i\/item\/9789241597531."},{"key":"5446_CR18","unstructured":"Population Size by Sex, Region, Zone and Wereda; 2023."},{"key":"5446_CR19","volume-title":"Essentials of medical parasitology","author":"AS Sastry","year":"2018","unstructured":"Sastry AS, Bhat S. Essentials of medical parasitology. 2nd ed. Jaypee Brothers Medical Publishers; 2018.","edition":"2"},{"key":"5446_CR20","unstructured":"WHO. Guideline on haemoglobin cutoffs to define anaemia in individuals and populations. Geneva: World Health Organization; 2024. https:\/\/iris.who.int\/bitstream\/handle\/10665\/376196\/9789240088542-eng.pdf?sequence=1"},{"key":"5446_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277362","volume":"18","author":"H Belay","year":"2023","unstructured":"Belay H, Alemu M, Hailu T, Mohammed H, Sime H, Hailegeorgies H, et al. Therapeutic efficacy of chloroquine for the treatment of uncomplicated Plasmodium vivax infection in Shewa Robit, Northeast Ethiopia. PLoS ONE. 2023;18: e0277362.","journal-title":"PLoS ONE"},{"key":"5446_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1756-3305-4-46","volume":"4","author":"T Ketema","year":"2011","unstructured":"Ketema T, Getahun K, Bacha K. Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Halaba District, South Ethiopia. Parasit Vectors. 2011;4:46.","journal-title":"Parasit Vectors"},{"key":"5446_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/IDR.S300692","volume":"14","author":"S Yeshanew","year":"2021","unstructured":"Yeshanew S, Dagne A, Taye B. Efficacy study of chloroquine to Plasmodium vivax malaria in Darimu and Bure Districts, Southwest Ethiopia. Infect Drug Resist. 2021;14:795\u2013803.","journal-title":"Infect Drug Resist"},{"key":"5446_CR24","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1128\/AAC.04270-14","volume":"59","author":"L Yuan","year":"2015","unstructured":"Yuan L, Wang Y, Parker DM, Gupta B, Yang Z, Liu H, Fan Q, Cao Y, Xiao Y. Lee M-c: Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in Northeastern Myanmar. Antimicrob Agents Chemother. 2015;59:1230\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"5446_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12936-024-05031-9","volume":"23","author":"H Gebrie","year":"2024","unstructured":"Gebrie H, Yimer M, Ayehu A, Mohammed H, Hailgiorgis H, Wuletaw Y, et al. Efficacy and safety of chloroquine plus primaquine for the treatment of Plasmodium vivax malaria in Hamusit site, Northwestern Ethiopia. Malar J. 2024;23:202.","journal-title":"Malar J"},{"key":"5446_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1475-2875-11-214","volume":"11","author":"N Townell","year":"2012","unstructured":"Townell N, Looke D, McDougall D, McCarthy JS. Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study. Malar J. 2012;11:214.","journal-title":"Malar J"},{"key":"5446_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157666","volume":"11","author":"K Saravu","year":"2016","unstructured":"Saravu K, Kumar R, Ashok H, Kundapura P, Kamath V, Kamath A, Mukhopadhyay C. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from Primary Care Centres in Southwestern India. PLoS ONE. 2016;11: e0157666.","journal-title":"PLoS ONE"},{"key":"5446_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4269\/ajtmh.18-0655","volume":"100","author":"E Mesa-Echeverry","year":"2019","unstructured":"Mesa-Echeverry E, Niebles-Bol\u00edvar M, Tob\u00f3n-Casta\u00f1o A. Chloroquine\u2013primaquine therapeutic efficacy, safety, and plasma levels in patients with uncomplicated Plasmodium vivax malaria in a Colombian Pacific Region. Am J Trop Med Hyg. 2019;100:72\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"5446_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4269\/ajtmh.12-0683","volume":"89","author":"G Zhu","year":"2013","unstructured":"Zhu G, Lu F, Cao J, Zhou H, Liu Y, Han E-T, et al. Blood stage of Plasmodium vivax in central China is still susceptible to chloroquine plus primaquine combination therapy. Am J Trop Med Hyg. 2013;89:184\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"5446_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.4269\/ajtmh.16-0075","volume":"95","author":"S Negreiros","year":"2016","unstructured":"Negreiros S, Farias S, Viana GMR, Okoth SA, Chenet SM, de Souza TMH, et al. Efficacy of chloroquine and primaquine for the treatment of uncomplicated Plasmodium vivax malaria in Cruzeiro do Sul, Brazil. Am J Trop Med Hyg. 2016;95:1061\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"5446_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12936-023-04562-x","volume":"22","author":"DA Mekonnen","year":"2023","unstructured":"Mekonnen DA, Abadura GS, Behaksra SW, Taffese HS, Bayissa GA, Bulto MG, et al. Treatment of uncomplicated Plasmodium vivax with chloroquine plus radical cure with primaquine without G6PDd testing is safe in Arba Minch, Ethiopia: assessment of clinical and parasitological response. Malar J. 2023;22:135.","journal-title":"Malar J"},{"key":"5446_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.actatropica.2009.10.001","volume":"113","author":"AK Yeshiwondim","year":"2010","unstructured":"Yeshiwondim AK, Tekle AH, Dengela DO, Yohannes AM, Teklehaimanot A. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia. Acta Trop. 2010;113:105\u201313.","journal-title":"Acta Trop"},{"key":"5446_CR33","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1128\/AAC.02050-12","volume":"57","author":"S Ganguly","year":"2013","unstructured":"Ganguly S, Saha P, Guha SK, Das S, Bera DK, Biswas A, et al. In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes. Antimicrob Agents Chemother. 2013;57:1246\u201351.","journal-title":"Antimicrob Agents Chemother"},{"key":"5446_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-12-409","volume":"12","author":"H Liu","year":"2013","unstructured":"Liu H, Yang HL, Xu JW, Wang JZ, Nie RH, Li CF. Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China. Malar J. 2013;12:1\u20137.","journal-title":"Malar J"},{"key":"5446_CR35","doi-asserted-by":"publisher","first-page":"e01965","DOI":"10.1128\/AAC.01965-18","volume":"63","author":"S Ladeia-Andrade","year":"2019","unstructured":"Ladeia-Andrade S, Menezes MJ, de Sousa TN, Silvino ACR, de Carvalho Jr JF, Salla LC, et al. Monitoring the efficacy of chloroquine-primaquine therapy for uncomplicated Plasmodium vivax malaria in the main transmission hot spot of Brazil. Antimicrob Agents Chemother. 2019;63:e01965-e2018.","journal-title":"Antimicrob Agents Chemother"},{"key":"5446_CR36","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1093\/cid\/ciy319","volume":"67","author":"CS Chu","year":"2018","unstructured":"Chu CS, Phyo AP, Lwin KM, Win HH, San T, Aung AA, et al. Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria. Clin Infect Dis. 2018;67:1543\u20139.","journal-title":"Clin Infect Dis"},{"key":"5446_CR37","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.4269\/ajtmh.17-0290","volume":"97","author":"GR Awab","year":"2017","unstructured":"Awab GR, Imwong M, Bancone G, Jeeyapant A, Day NP, White NJ, et al. Chloroquine\u2013primaquine versus chloroquine alone to treat vivax malaria in Afghanistan: an open randomized superiority trial. Am J Trop Med Hyg. 2017;97:1782.","journal-title":"Am J Trop Med Hyg"},{"key":"5446_CR38","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S1473-3099(18)30348-7","volume":"18","author":"RJ Commons","year":"2018","unstructured":"Commons RJ, Simpson JA, Thriemer K, Humphreys GS, Abreha T, Alemu SG, et al. The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a Worldwide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis. Lancet Infect Dis. 2018;18:1025\u201334.","journal-title":"Lancet Infect Dis"},{"key":"5446_CR39","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1517\/14656560902942319","volume":"10","author":"U D\u2019Alessandro","year":"2009","unstructured":"D\u2019Alessandro U. Existing antimalarial agents and malaria-treatment strategies. Expert Opin Pharmacother. 2009;10:1291\u2013306.","journal-title":"Expert Opin Pharmacother"},{"key":"5446_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2019.101499","volume":"36","author":"S Xu","year":"2020","unstructured":"Xu S, Zeng W, Mbenda HGN, Liu H, Chen X, Xiang Z, et al. Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in Northeast Myanmar: a prospective open-label efficacy trial. Travel Med Infect Dis. 2020;36: 101499.","journal-title":"Travel Med Infect Dis"},{"key":"5446_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104698","volume":"88","author":"G Sorci","year":"2021","unstructured":"Sorci G, L\u00e9chenault-Bergerot C, Faivre B. Age reduces resistance and tolerance in malaria-infected mice. Infect Genet Evol. 2021;88: 104698.","journal-title":"Infect Genet Evol"},{"key":"5446_CR42","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.40150","volume":"7","author":"M White","year":"2018","unstructured":"White M, Watson J. Age, exposure and immunity. Elife. 2018;7: e40150.","journal-title":"Elife"},{"key":"5446_CR43","unstructured":"WHO. Guidelines for malaria, 2022. Geneva: World Health Organization; 2022. https:\/\/iris.who.int\/bitstream\/handle\/10665\/351995\/WHO-UCN-GMP-2022.01-eng.pdf."},{"key":"5446_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12936-017-1731-1","volume":"16","author":"NJ White","year":"2017","unstructured":"White NJ. Malaria parasite clearance. Malar J. 2017;16:88.","journal-title":"Malar J"},{"key":"5446_CR45","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","volume":"14","author":"RN Price","year":"2014","unstructured":"Price RN, Von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:982\u201391.","journal-title":"Lancet Infect Dis"},{"key":"5446_CR46","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12936-018-2509-9","volume":"17","author":"NJ White","year":"2018","unstructured":"White NJ. Anaemia and malaria. Malar J. 2018;17:371.","journal-title":"Malar J"},{"key":"5446_CR47","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1475-2875-11-135","volume":"11","author":"NM Douglas","year":"2012","unstructured":"Douglas NM, Anstey NM, Buffet PA, Poespoprodjo JR, Yeo TW, White NJ, et al. The anaemia of Plasmodium vivax malaria. Malar J. 2012;11:135.","journal-title":"Malar J"},{"key":"5446_CR48","volume":"2015","author":"AC Martins","year":"2015","unstructured":"Martins AC, Cayotopa ADE, Klein WW, Schlosser AR, Silva AFD, Souza MND, et al. Side effects of chloroquine and primaquine and symptom reduction in malaria endemic area (M\u00e2ncio Lima, Acre, Brazil). Interdiscip Perspect Infect Dis. 2015;2015: 346853.","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"5446_CR49","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12936-019-2981-x","volume":"18","author":"E Lo","year":"2019","unstructured":"Lo E, Zhong D, Raya B, Pestana K, Koepfli C, Lee M-C, et al. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia. Malar J. 2019;18:340.","journal-title":"Malar J"},{"key":"5446_CR50","unstructured":"WHO. Testing for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale malaria: Policy Brief. Geneva: World Health Organization; 2016. https:\/\/iris.who.int\/bitstream\/handle\/10665\/250297\/WHO-HTM-GMP-2016.9-eng.pdf?sequence=1."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05446-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05446-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05446-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T08:02:45Z","timestamp":1750060965000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05446-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5446"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05446-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,15]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Ethiopian Public Health Institute (EPHI-IRB294-2022). Written informed consent was obtained from all participants, with assent from children aged \u2265\u200912 years. Participants received transportation reimbursement and insecticide-treated nets. Privacy and confidentiality were maintained throughout the study period by excluding personal identifiers during data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}